Fiche du document
19 février 2024
- doi: 10.58079/vv4y
info:eu-repo/semantics/openAccess
Sujets proches
Conation Volition Cetanā Controlled clinical trials Randomized clinical trials Trials, Clinical Patient trials of new treatmentsCiter ce document
adelage, « FDA - Clinical Trials: The Patient Experience (Catapult's regulatory round-up - March) », ELSIBI, ID : 10.58079/vv4y
Métriques
Partage / Export
Résumé
On the 13th of April 2023, the FDA’s Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP) will host a public virual workshop. The workshop will feature a panel of rare disease patients as well as caregivers and advocates share their experiences with gene therapy clinical trials. Please find further details on this event, including how to register here. Published on the 3rd of April 2023 in Catapult's March regulatory round-up.